Your session is about to expire
← Back to Search
Procedure
Surgery for Constipation (PROD Trial)
N/A
Recruiting
Led By Ghazaleh Rostami Nia, MD
Research Sponsored by NorthShore University HealthSystem
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Rectal hypermobility defined as a compression ratio greater than 50% according to ultrasound
Patient planning on undergoing surgery for the repair of pelvic organ prolapse
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months post-operatively
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to compare two surgical procedures for treating the inability to completely empty the bowels in women. One procedure is called laparoscopic abdominal ventral rectopexy, which is a common
Who is the study for?
This trial is for adult women suffering from obstructive defecatory syndrome (ODS), who often strain, can't fully empty their bowels, or need to manually assist bowel movements. Participants must be able to complete study assessments and provide consent, have rectal hypermobility as shown by ultrasound, and commit to a 24-month follow-up.
What is being tested?
The trial compares two surgeries for ODS: laparoscopic abdominal ventral rectopexy and transvaginal sacrospinous rectopexy. Women will be randomly assigned one of these procedures and followed up at intervals over two years to assess symptoms and surgical success.
What are the potential side effects?
Potential side effects may include discomfort or pain at the surgery site, bleeding, infection risk post-surgery, possible pelvic organ injury during operation, and general anesthesia risks.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My ultrasound shows my rectum moves more than normal.
Select...
I am planning to have surgery for pelvic organ prolapse.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 months post-operatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months post-operatively
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Degree of rectal hypermobility measured via ultrasound
Secondary study objectives
Global improvement in bladder function
Pelvic Floor Distress Inventory (PFDI) - CRADI
Pelvic Floor Distress Inventory (PFDI) - POPDI
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Transvaginal sacrospinous rectopexyExperimental Treatment1 Intervention
Group II: Laparoscopic abdominal ventral rectopexyExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityOTHER
1,091 Previous Clinical Trials
1,154,630 Total Patients Enrolled
1 Trials studying Pelvic Organ Prolapse
170 Patients Enrolled for Pelvic Organ Prolapse
NorthShore University HealthSystemLead Sponsor
132 Previous Clinical Trials
737,526 Total Patients Enrolled
1 Trials studying Pelvic Organ Prolapse
114 Patients Enrolled for Pelvic Organ Prolapse
University of PittsburghOTHER
1,792 Previous Clinical Trials
16,359,860 Total Patients Enrolled
4 Trials studying Pelvic Organ Prolapse
486 Patients Enrolled for Pelvic Organ Prolapse
Ghazaleh Rostami Nia, MDPrincipal InvestigatorEndeavor Health
2 Previous Clinical Trials
205 Total Patients Enrolled